2-chloro-2’-deoxyadenosine (2-CdA)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	23

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 10 of 23 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-002631-42-FI (EUCTR)	26/06/2018	28/02/2018	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech Republic; ...
2	EUCTR2017-002631-42-GB (EUCTR)	21/05/2018	18/12/2017	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	265	Phase 4	Finland;Spain;Ireland;Austria;Israel;Italy;United Kingdom;Switzerland;France;Hungary;Czech Republic; ...
3	EUCTR2017-002631-42-BE (EUCTR)	09/05/2018	22/02/2018	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary; ...
4	EUCTR2017-002631-42-CZ (EUCTR)	25/04/2018	30/01/2018	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	265	Phase 4	Czechia;Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech R ...
5	EUCTR2017-002631-42-SE (EUCTR)	18/04/2018	05/12/2017	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	265	Phase 4	Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary; ...
6	EUCTR2017-002631-42-FR (EUCTR)	10/04/2018	14/02/2018	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech Republic; ...
7	EUCTR2017-002631-42-HU (EUCTR)	26/02/2018	28/12/2017	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	300	Phase 4	Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech Republic; ...
8	EUCTR2017-002631-42-AT (EUCTR)	19/02/2018	11/01/2018	A Clinical Research Study for People with Relapsing Multiple Sclerosis	A 2-year prospective study to evaluate the onset of action of Mavenclad® in subjects with highly act ...	Relapsing multiple sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multi ...	Trade Name: Mavenclad® Product Name: Cladribine INN or Proposed INN: CLADRIBINE Other descriptive name: ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	265	Phase 4	Czechia;Finland;Spain;Ireland;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic; ...
9	EUCTR2007-000381-20-BG (EUCTR)	28/10/2008	20/10/2008	CLARITY Extension Study	A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Eval ...	Relapsing Remitting Multiple Sclerosis (RRMS) MedDRA version: 14.0;Level: PT;Classification code 100 ...	Product Name: cladribine Product Code: Not Applicable INN or Proposed INN: CLADRIBINE Other descriptive ...	Merck Serono S.A. - Geneva	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	Germany;Bulgaria;France;Austria;Australia;Brazil;Czech Republic;Serbia;Canada;Belgium;United States; ...
10	EUCTR2007-000381-20-GR (EUCTR)	09/09/2008	01/04/2008		A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Eval ...	Relapsing Remitting Multiple Sclerosis (RRMS) MedDRA version: 9.1;Level: PT;Classification code 1002 ...	Product Name: cladribine Product Code: Not Applicable INN or Proposed INN: CLADRIBINE Other descriptive ...	Merck Serono International S.A.	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	Czech Republic;Denmark;Estonia;Greece;Portugal;Germany;Netherlands;Bulgaria;France;Italy;Austria;Lit ...

First Previous1 2 3Next Last